Select Committee on Health Minutes of Evidence


Supplementary documents provided to the Committee[46]

  Is Yasmin a truly different pill? DTB 2002; 40: 57-9.

  Yasmin advert withdrawn—why and how. DTB 2003; 41: 17-8.

  Pimecrolimus cream for atopic dermatitis. DTB 2003; 41: 33-6.

  Is Cerazette the minipill of choice? DTB 2003; 41: 68-9.

  Memantine for dementia? DTB 2003; 41: 73-6.

  Evra—a patch on oral contraception? DTB 2003; 41: 89-91.

  Caspofungin and voriconazole for fungal infections. DTB 2004; 42: 5-8.

  Moxifloxacin—a new fluoroquinolone antibacterial. DTB 2004; 42: 61-2.

  Patient information: what's the prognosis? CA policy report February 2003.

  Patient information: what's the prognosis? CA briefing paper, January 2003.

  Who's injecting the cash? Which? April 2003.pp 24-25.

  Promotion of prescription drugs: public health or private profit? CA policy report, July 2001.

  Meek, C. "Marketing drugs". Health Which? June 2003.

  Patient information leaflets: sick notes? CA policy paper, June 2000.







46   Not printed. Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 26 April 2005